SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-23-000996
Filing Date
2023-01-31
Accepted
2023-01-31 16:15:02
Documents
1
Group Members
PATRICK G. G. DEARREADE E. GRIFFITHTETRAGON FINANCIAL GROUP LTDTETRAGON FINANCIAL MANAGEMENT L.P.

Document Format Files

Seq Description Document Type Size
1 FREELINE THERAPEUTICS HOLDINGS PLC p23-0492sc13ga.htm SC 13G/A 86463
  Complete submission text file 0000902664-23-000996.txt   88315
Mailing Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 359-7300
Tetragon Financial Management LP (Filed by) CIK: 0001758892 (see all company filings)

IRS No.: 203311552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP
Business Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Subject) CIK: 0001810031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91620 | Film No.: 23572724
SIC: 2836 Biological Products, (No Diagnostic Substances)